These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 38610930)

  • 21. Hitting the Bull's-Eye: Mesothelin's Role as a Biomarker and Therapeutic Target for Malignant Pleural Mesothelioma.
    Yeo D; Castelletti L; van Zandwijk N; Rasko JEJ
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in
    Oehl K; Vrugt B; Wagner U; Kirschner MB; Meerang M; Weder W; Felley-Bosco E; Wollscheid B; Bankov K; Demes MC; Opitz I; Wild PJ
    Clin Cancer Res; 2021 Apr; 27(8):2277-2291. PubMed ID: 33547197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition.
    de Reyniès A; Jaurand MC; Renier A; Couchy G; Hysi I; Elarouci N; Galateau-Sallé F; Copin MC; Hofman P; Cazes A; Andujar P; Imbeaud S; Petel F; Pairon JC; Le Pimpec-Barthes F; Zucman-Rossi J; Jean D
    Clin Cancer Res; 2014 Mar; 20(5):1323-34. PubMed ID: 24443521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repurposing therapeutics for malignant pleural mesothelioma (MPM) - Updates on clinical translations and future outlook.
    Kulkarni NS; Gupta V
    Life Sci; 2022 Sep; 304():120716. PubMed ID: 35709894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition.
    Srinivasan G; Sidhu GS; Williamson EA; Jaiswal AS; Najmunnisa N; Wilcoxen K; Jones D; George TJ; Hromas R
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):861-867. PubMed ID: 28756516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomics and Functional Genomics of Malignant Pleural Mesothelioma.
    Cakiroglu E; Senturk S
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The established and future biomarkers of malignant pleural mesothelioma.
    Panou V; Vyberg M; Weinreich UM; Meristoudis C; Falkmer UG; Røe OD
    Cancer Treat Rev; 2015 Jun; 41(6):486-95. PubMed ID: 25979846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Advances in Immunotherapy for Malignant Pleural Mesothelioma].
    Chi Y; Liu Y; Zhao J
    Zhongguo Fei Ai Za Zhi; 2022 Apr; 25(4):259-265. PubMed ID: 35477190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anti-tumor immunotherapy in malignant pleural mesothelioma].
    Scherpereel A; Willemin MC; Wasielewski E; Dhalluin X
    Rev Mal Respir; 2018 Apr; 35(4):465-476. PubMed ID: 29415822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New therapeutic strategies for malignant pleural mesothelioma.
    Bonelli MA; Fumarola C; La Monica S; Alfieri R
    Biochem Pharmacol; 2017 Jan; 123():8-18. PubMed ID: 27431778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current efforts in research of pleural mesothelioma-An analysis of the ClinicalTrials.gov registry.
    Süveg K; Putora PM; Berghmans T; Glatzer M; Kovac V; Cihoric N
    Lung Cancer; 2018 Oct; 124():12-18. PubMed ID: 30268449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel systemic therapy against malignant pleural mesothelioma.
    Mancuso MR; Neal JW
    Transl Lung Cancer Res; 2017 Jun; 6(3):295-314. PubMed ID: 28713675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study.
    Zauderer MG; Martin A; Egger J; Rizvi H; Offin M; Rimner A; Adusumilli PS; Rusch VW; Kris MG; Sauter JL; Ladanyi M; Shen R
    Lancet Digit Health; 2021 Sep; 3(9):e565-e576. PubMed ID: 34332931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study.
    Cova E; Pandolfi L; Colombo M; Frangipane V; Inghilleri S; Morosini M; Mrakic-Sposta S; Moretti S; Monti M; Pignochino Y; Benvenuti S; Prosperi D; Stella G; Morbini P; Meloni F
    Int J Nanomedicine; 2019; 14():773-785. PubMed ID: 30774332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large-scale analysis of BAP1 expression reveals novel associations with clinical and molecular features of malignant pleural mesothelioma.
    De Rienzo A; Chirieac LR; Hung YP; Severson DT; Freyaldenhoven S; Gustafson CE; Dao NT; Meyerovitz CV; Oster ME; Jensen RV; Yeap BY; Bueno R; Richards WG
    J Pathol; 2021 Jan; 253(1):68-79. PubMed ID: 32944962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescence in situ hybridization detection of chromosome 22 monosomy in pleural effusion cytology for the diagnosis of mesothelioma.
    Kinoshita Y; Hamasaki M; Matsumoto S; Yoshimura M; Sato A; Tsujimura T; Kamei T; Kawahara K; Iwasaki A; Nabeshima K
    Cancer Cytopathol; 2021 Jul; 129(7):526-536. PubMed ID: 33493384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
    Cantini L; Hassan R; Sterman DH; Aerts JGJV
    Front Oncol; 2020; 10():343. PubMed ID: 32226777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Malignant pleural mesothelioma: 2013 state of the art].
    Campbell K; Brosseau S; Reviron-Rabec L; Bergot E; Lechapt E; Levallet G; Zalcman G
    Bull Cancer; 2013 Dec; 100(12):1283-93. PubMed ID: 24225007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma.
    Yang H; Hall SRR; Sun B; Zhao L; Gao Y; Schmid RA; Tan ST; Peng RW; Yao F
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33805359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic Deletion of
    Sarun KH; Lee K; Williams M; Wright CM; Clarke CJ; Cheng NC; Takahashi K; Cheng YY
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.